HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b

MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5

(2012) Xue-Mei Xu et al.   CANCER LETTERS

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity

(2012) K. R. Bosse et al.   CANCER RESEARCH

Molecular Pathways: The Complexity of the Epigenome in Cancer and Recent Clinical Advances

(2012) M. Conte et al.   CLINICAL CANCER RESEARCH

Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

(2012) Guillermo Garcia-Manero et al.   JOURNAL OF CLINICAL ONCOLOGY

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

(2011) Leonardo Salmena et al.   CELL

BARD1 Expression Predicts Outcome in Colon Cancer

(2011) Judith C. Sporn et al.   CLINICAL CANCER RESEARCH

MicroRNAs and epigenetics

(2011) Fumiaki Sato et al.   FEBS Journal

BARD1: An independent predictor of survival in non-small cell lung cancer

(2011) Yong-Qiang Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

mir-17-92, a cluster of miRNAs in the midst of the cancer network

(2010) Virginie Olive et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia

(2010) Konstantinos J. Mavrakis et al.   NATURE CELL BIOLOGY

Histone deacetylases and epigenetic therapies of hematological malignancies

(2010) Ciro Mercurio et al.   PHARMACOLOGICAL RESEARCH

A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation

(2010) Dorothy Beckett et al.   PROTEIN SCIENCE

Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1  Scaffolds Aurora B and BRCA2

(2009) S. Ryser et al.   CANCER RESEARCH

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes

(2009) Angela Nebbioso et al.   EMBO REPORTS

BARD1, a possible biomarker for breast and ovarian cancer

(2009) Irmgard Irminger-Finger   GYNECOLOGIC ONCOLOGY

The complexities of microRNA regulation: mirandering around the rules

(2009) Kimberly Breving et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

RNA interference as a gene knockdown technique

(2009) Ge Shan   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The BARD1 C-Terminal Domain Structure and Interactions with Polyadenylation Factor CstF-50†

(2008) Ross A. Edwards et al.   BIOCHEMISTRY

Destabilization of ERBB2 Transcripts by Targeting 3' Untranslated Region Messenger RNA Associated HuR and Histone Deacetylase-6

(2008) G. K. Scott et al.   MOLECULAR CANCER RESEARCH